Discovery of a New Class of Uracil Derivatives as Potential Mixed Lineage Kinase Domain-like Protein (MLKL) Inhibitors

被引:17
作者
Cui, Bo [1 ,2 ]
Yan, Bo [2 ]
Wang, Kang [2 ]
Li, Lin [2 ]
Chen, She [2 ]
Zhang, Zhiyuan [2 ]
机构
[1] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China
[2] NIBS, Beijing 102206, Peoples R China
关键词
HIGHLY POTENT; NECROPTOSIS; PHOSPHORYLATION; MECHANISMS; NECROSIS; RIP1;
D O I
10.1021/acs.jmedchem.2c00548
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Necroptosis is a form of programmed cell death. Mixed lineage kinase domain-like protein (MLKL) is the necroptosis executor, and it is involved in various diseases such as tissue damage and neurodegeneration-related diseases. Here, we report the development of novel MLKL inhibitors with a uracil nucleus through scaffold morphing from our previously reported xanthine MLKL inhibitor TC13172. After a rational structure- activity relationship study, we obtained the highly potent compounds 56 and 66. Mechanism studies revealed that these compounds partially inhibited MLKL oligomerization and significantly inhibited MLKL translocation to the membrane. Compared with TC13172, 56 and 66 have a different mode of action and, importantly, their reaction rate with glutathione is more than 150-fold lower. This reduction in potential off-target effects and cell toxicity makes this series an attractive starting point for further drug development for MLKL-related disease treatments.
引用
收藏
页码:12747 / 12780
页数:34
相关论文
共 32 条
[1]   Understanding allosteric interactions in hMLKL protein that modulate necroptosis and its inhibition [J].
Bansal, Nupur ;
Sciabola, Simone ;
Bhisetti, Govinda .
SCIENTIFIC REPORTS, 2019, 9 (1)
[2]   Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation [J].
Cho, YoungSik ;
Challa, Sreerupa ;
Moquin, David ;
Genga, Ryan ;
Ray, Tathagat Dutta ;
Guildford, Melissa ;
Chan, Francis Ka-Ming .
CELL, 2009, 137 (06) :1112-1123
[3]   The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis [J].
Davies, Katherine A. ;
Tanzer, Maria C. ;
Griffin, Michael D. W. ;
Mok, Yee Foong ;
Young, Samuel N. ;
Qin, Rui ;
Petrie, Emma J. ;
Czabotar, Peter E. ;
Silke, John ;
Murphy, James M. .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (09) :1567-1580
[4]   Apoptosis: A review of programmed cell death [J].
Elmore, Susan .
TOXICOLOGIC PATHOLOGY, 2007, 35 (04) :495-516
[5]   A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis [J].
Fauster, A. ;
Rebsamen, M. ;
Huber, K. V. M. ;
Bigenzahn, J. W. ;
Stukalov, A. ;
Lardeau, C-H ;
Scorzoni, S. ;
Bruckner, M. ;
Gridling, M. ;
Parapatics, K. ;
Colinge, J. ;
Bennett, K. L. ;
Kubicek, S. ;
Krautwald, S. ;
Linkermann, A. ;
Superti-Furga, G. .
CELL DEATH & DISEASE, 2015, 6 :e1767-e1767
[6]   Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 [J].
Galluzzi, Lorenzo ;
Vitale, Ilio ;
Aaronson, Stuart A. ;
Abrams, John M. ;
Adam, Dieter ;
Agostinis, Patrizia ;
Alnemri, Emad S. ;
Altucci, Lucia ;
Amelio, Ivano ;
Andrews, David W. ;
Annicchiarico-Petruzzelli, Margherita ;
Antonov, Alexey V. ;
Arama, Eli ;
Baehrecke, Eric H. ;
Barlev, Nickolai A. ;
Bazan, Nicolas G. ;
Bernassola, Francesca ;
Bertrand, Mathieu J. M. ;
Bianchi, Katiuscia ;
Blagosklonny, Mikhail V. ;
Blomgren, Klas ;
Borner, Christoph ;
Boya, Patricia ;
Brenner, Catherine ;
Campanella, Michelangelo ;
Candi, Eleonora ;
Carmona-Gutierrez, Didac ;
Cecconi, Francesco ;
Chan, Francis K. -M. ;
Chandel, Navdeep S. ;
Cheng, Emily H. ;
Chipuk, Jerry E. ;
Cidlowski, John A. ;
Ciechanover, Aaron ;
Cohen, Gerald M. ;
Conrad, Marcus ;
Cubillos-Ruiz, Juan R. ;
Czabotar, Peter E. ;
D'Angiolella, Vincenzo ;
Dawson, Ted M. ;
Dawson, Valina L. ;
De laurenzi, Vincenzo ;
De Maria, Ruggero ;
Debatin, Klaus-Michael ;
DeBerardinis, Ralph J. ;
Deshmukh, Mohanish ;
Di Daniele, Nicola ;
Di Virgilio, Francesco ;
Dixit, Vishva M. ;
Dixon, Scott J. .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (03) :486-541
[7]   Necroptosis: A new way of dying? [J].
Hanson, Britt .
CANCER BIOLOGY & THERAPY, 2016, 17 (09) :899-910
[8]   Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases [J].
Harris, Philip A. ;
Berger, Scott B. ;
Jeong, Jae U. ;
Nagilla, Rakesh ;
Bandyopadhyay, Deepak ;
Campobasso, Nino ;
Capriotti, Carol A. ;
Cox, Julie A. ;
Dare, Lauren ;
Dong, Xiaoyang ;
Eidam, Patrick M. ;
Finger, Joshua N. ;
Hoffman, Sandra J. ;
Kang, James ;
Kasparcova, Viera ;
King, Bryan W. ;
Lehr, Ruth ;
Lan, Yunfeng ;
Leister, Lara K. ;
Lich, John D. ;
MacDonald, Thomas T. ;
Miller, Nathan A. ;
Ouellette, Michael T. ;
Pao, Christina S. ;
Rahman, Attiq ;
Reilly, Michael A. ;
Rendina, Alan R. ;
Rivera, Elizabeth J. ;
Schaeffer, Michelle C. ;
Sehon, Clark A. ;
Singhaus, Robert R. ;
Sun, Helen H. ;
Swift, Barbara A. ;
Totoritis, Rachel D. ;
Vossenkaemper, Anna ;
Ward, Paris ;
Wisnoski, David D. ;
Zhang, Daohua ;
Marquis, Robert W. ;
Gough, Peter J. ;
Bertin, John .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (04) :1247-1261
[9]   Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α [J].
He, Sudan ;
Wang, Lai ;
Miao, Lin ;
Wang, Tao ;
Du, Fenghe ;
Zhao, Liping ;
Wang, Xiaodong .
CELL, 2009, 137 (06) :1100-1111
[10]   Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death [J].
Hildebrand, Joanne M. ;
Tanzer, Maria C. ;
Lucet, Isabelle S. ;
Young, Samuel N. ;
Spall, Sukhdeep K. ;
Sharma, Pooja ;
Pierotti, Catia ;
Garnier, Jean-Marc ;
Dobson, Renwick C. J. ;
Webb, Andrew I. ;
Tripaydonis, Anne ;
Babon, Jeffrey J. ;
Mulcair, Mark D. ;
Scanlon, Martin J. ;
Alexander, Warren S. ;
Wilks, Andrew F. ;
Czabotar, Peter E. ;
Lessene, Guillaume ;
Murphy, James M. ;
Silke, John .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (42) :15072-15077